Nuclear Receptor Nr4a1 Regulates Striatal Striosome Development and Dopamine D
Animals
Animals, Newborn
Cells, Cultured
Cocaine
/ pharmacology
Corpus Striatum
/ cytology
Dopamine Uptake Inhibitors
/ pharmacology
Humans
Locomotion
/ drug effects
Male
Mice
Mice, Knockout
Mice, Transgenic
Neurons
/ drug effects
Nuclear Receptor Subfamily 4, Group A, Member 1
/ biosynthesis
Receptors, Dopamine D1
/ biosynthesis
Signal Transduction
/ drug effects
ERK
Nr4a1
dopamine receptor D1
signal
striosome
transduction
Journal
eNeuro
ISSN: 2373-2822
Titre abrégé: eNeuro
Pays: United States
ID NLM: 101647362
Informations de publication
Date de publication:
Historique:
received:
02
08
2019
revised:
28
08
2019
accepted:
29
08
2019
pubmed:
22
9
2019
medline:
31
3
2020
entrez:
22
9
2019
Statut:
epublish
Résumé
The GABAergic medium-size spiny neuron (MSN), the striatal output neuron, may be classified into striosome, also known as patch, and matrix, based on neurochemical differences between the two compartments. At this time, little is known regarding the regulation of the development of the two compartments.
Identifiants
pubmed: 31541002
pii: ENEURO.0305-19.2019
doi: 10.1523/ENEURO.0305-19.2019
pmc: PMC6787343
pii:
doi:
Substances chimiques
Dopamine Uptake Inhibitors
0
Drd1 protein, mouse
0
Nr4a1 protein, mouse
0
Nuclear Receptor Subfamily 4, Group A, Member 1
0
Receptors, Dopamine D1
0
Cocaine
I5Y540LHVR
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDA NIH HHS
ID : K02 DA026405
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS100529
Pays : United States
Informations de copyright
Copyright © 2019 Cirnaru et al.
Références
J Neurochem. 2008 Jul;106(2):875-88
pubmed: 18466322
J Neurosci. 1997 Jun 15;17(12):4536-44
pubmed: 9169514
Mol Pharmacol. 2018 Oct;94(4):1174-1186
pubmed: 30111648
Med Sci (Paris). 2005 May;21(5):453-4
pubmed: 15885186
J Neurosci. 2002 Sep 15;22(18):7931-40
pubmed: 12223546
Science. 1995 Jul 28;269(5223):532-5
pubmed: 7624775
Neuropharmacology. 2013 Dec;75:78-85
pubmed: 23891638
J Neurosci. 2007 Jun 27;27(26):6995-7005
pubmed: 17596448
Brain Struct Funct. 2018 Dec;223(9):4275-4291
pubmed: 30203304
Neuroscience. 2013 Jun 25;241:215-28
pubmed: 23518224
J Neurosci. 2010 Mar 3;30(9):3499-507
pubmed: 20203210
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3908-13
pubmed: 16537460
J Neurochem. 1995 Jun;64(6):2534-43
pubmed: 7760033
Neurobiol Dis. 2009 Oct;36(1):213-22
pubmed: 19635563
Neuropsychopharmacology. 2011 Sep;36(10):2041-53
pubmed: 21654736
Biol Psychiatry. 2006 Sep 15;60(6):538-47
pubmed: 16893530
Mol Cell Neurosci. 2010 May;44(1):94-108
pubmed: 20197093
Front Endocrinol (Lausanne). 2018 Apr 18;9:173
pubmed: 29720962
Genes Dev. 2017 Sep 1;31(17):1809-1820
pubmed: 28982763
Biol Psychiatry. 2007 Oct 1;62(7):800-10
pubmed: 17662258
Brain Res Mol Brain Res. 2000 Mar 10;76(1):18-24
pubmed: 10719211
Curr Opin Pharmacol. 2007 Feb;7(1):77-85
pubmed: 17085074
Front Neuroanat. 2017 Mar 21;11:20
pubmed: 28377698
Biol Psychiatry. 2014 Dec 15;76(12):917-26
pubmed: 24844603
ACS Chem Neurosci. 2017 Feb 15;8(2):235-242
pubmed: 27977131
J Immunol. 2014 May 15;192(10):4852-8
pubmed: 24740500
Exp Neurol. 2018 Jun;304:143-153
pubmed: 29530712
Elife. 2015 Nov 27;4:null
pubmed: 26613416
Eur J Neurosci. 2013 Jul;38(1):2192-8
pubmed: 23551242
Biol Psychiatry. 2004 Oct 1;56(7):522-6
pubmed: 15450789
J Immunol. 2017 May 15;198(10):3878-3885
pubmed: 28411187
Ann N Y Acad Sci. 2008 Oct;1139:1-9
pubmed: 18991842
Nature. 2007 Feb 8;445(7128):643-7
pubmed: 17287809
Neurobiol Dis. 2003 Oct;14(1):98-109
pubmed: 13678671
Eur J Neurosci. 2004 Apr;19(7):1826-36
pubmed: 15078556
J Neurosci. 2018 Feb 28;38(9):2177-2188
pubmed: 29371319
Adv Exp Med Biol. 2012;970:407-29
pubmed: 22351066
Front Behav Neurosci. 2014 Apr 03;8:111
pubmed: 24772073
Biol Psychiatry. 2015 Jan 15;77(2):106-15
pubmed: 24844602
J Neurosci. 2012 Apr 25;32(17):5900-10
pubmed: 22539851
J Neurochem. 2000 Oct;75(4):1694-702
pubmed: 10987852
Neurobiol Dis. 2018 Dec;120:88-97
pubmed: 30176350
J Neurophysiol. 2000 Sep;84(3):1422-9
pubmed: 10980015
Neuroscience. 2013 Oct 22;251:2-20
pubmed: 23867772
J Neurosci. 2012 May 16;32(20):6808-18
pubmed: 22593050
J Neurosci. 2009 Mar 18;29(11):3529-37
pubmed: 19295158
Br J Pharmacol. 2006 Mar;147(6):671-80
pubmed: 16415903
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Alcohol Clin Exp Res. 2009 Jan;33(1):121-8
pubmed: 18945217
Drug Alcohol Depend. 2012 Mar 1;121(3):173-80
pubmed: 22129844
Neuropsychopharmacology. 2003 Mar;28(3):478-89
pubmed: 12629527
Prog Mol Biol Transl Sci. 2012;106:33-62
pubmed: 22340713
J Neurosci. 2008 Oct 22;28(43):10814-24
pubmed: 18945889
J Neurosci. 2013 Jun 19;33(25):10427-38
pubmed: 23785154
J Neurosci. 2011 Jan 5;31(1):126-32
pubmed: 21209197
Science. 2008 Aug 8;321(5890):848-51
pubmed: 18687967
Endocr Rev. 1999 Oct;20(5):689-725
pubmed: 10529899
Cell Rep. 2015 Nov 17;13(7):1353-1365
pubmed: 26549453
PLoS One. 2011 Jan 28;6(1):e16619
pubmed: 21305052
Front Neuroanat. 2011 Sep 07;5:59
pubmed: 21941467
Brain Res. 2000 Apr 28;863(1-2):112-9
pubmed: 10773199
Sci Signal. 2012 Aug 28;5(239):ra63
pubmed: 22932702
Brain Res Mol Brain Res. 1996 Sep 5;41(1-2):111-20
pubmed: 8883941
J Neurosci. 2008 Mar 12;28(11):2681-5
pubmed: 18337395
Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2892-6
pubmed: 19171906
Neuron. 2014 Jul 16;83(2):431-443
pubmed: 24976215
BMC Neurosci. 2006 Mar 02;7:20
pubmed: 16512905
Neuron. 2018 Feb 21;97(4):787-795.e6
pubmed: 29398356